Alain Laroze

Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors

Françoise Gellibert, James M. Woolven, Marie-Hélène Fouchet et al. · Journal of Medicinal Chemistry · 2004 · 222 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Inhibition of TGF‐<i>β</i> signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis

Anne‐Charlotte de Gouville, Valérie Boullay, Gaël Krysa et al. · British Journal of Pharmacology · 2005 · 165 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents

Michael L. Sierra, Véronique Bénéton, Anne-Bénédict Boullay et al. · Journal of Medicinal Chemistry · 2007 · 120 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis and biological activities of novel indole derivatives as potent and selective PPARγ modulators

Yann Lamotte, Paul Martres, Nicolas Faucher et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton Syndrome

John Liddle, Véronique Bénéton, Matthew A. Benson et al. · Journal of Investigative Dermatology · 2021 · 32 citations

Medicine, Dermatology, Pharmacology +2